Jason Yeo, 54, a travelling sales manager from Devon, was shocked to discover his diagnosis in April 2024. He previously ...
Jason Yeo, from Devon, was shocked when an at home PSA test bought by his wife in early 2023, showed he 'needed to take further action' despite not suffering any symptoms.
PAM50, a genomic biomarker test, can classify prostate cancers into subtypes luminal B and non-luminal B, predicting which ...
After finding the charity Prost8, founded by Paul Sayer, Jason got a referral letter for treatment from his GP, which he said ...
Jason Yeo was shocked to discover he had prostate cancer in April 2024 as he was healthy, sporty and ‘symptomless’.
News-Medical.Net on MSN
Gene expression test identifies prostate cancer patients who benefit from hormone therapy
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
News-Medical.Net on MSN
Five-session SBRT reduces side effects in intermediate-risk prostate cancer
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results